Bloomberg Law | August 24, 2023
The companies are leaning on their outside law firms’ “heavy hitters” said Andrew Twinamatsiko, associate director of the Health Policy and the Law Initiative at Georgetown University’s O’Neill Institute.
Lawrence Gostin, a professor at Georgetown Law, said the legal army being assembled by pharmaceutical companies is “part of a well organized and lavishly funded attempt to use the courts to strike down a signature Biden initiative.”